HomeBLRX • TLV
BioLine RX Ltd
ILA 28.30
Mar 28, 5:24:57 PM GMT+2 · ILA · TLV · Disclaimer
StockIL listed security
Previous close
ILA 27.90
Day range
ILA 27.60 - ILA 28.80
Year range
ILA 17.80 - ILA 70.00
Market cap
83.20M USD
Avg Volume
909.30K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
In the news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2023Y/Y change
Revenue
Operating expense
12.36M74.58%
Net income
-16.02M-134.01%
Net profit margin
Earnings per share
-0.30-100.00%
EBITDA
-12.14M-75.25%
Effective tax rate
Total assets
Total liabilities
(USD)Sep 2023Y/Y change
Cash and short-term investments
25.97M-54.65%
Total assets
52.86M-35.28%
Total liabilities
39.72M51.90%
Total equity
13.13M
Shares outstanding
969.92M
Price to book
27.90
Return on assets
-55.27%
Return on capital
-101.22%
Net change in cash
(USD)Sep 2023Y/Y change
Net income
-16.02M-134.01%
Cash from operations
-9.90M-14.04%
Cash from investing
4.10M127.43%
Cash from financing
3.50M-84.60%
Net change in cash
-2.38M-165.59%
Free cash flow
-6.88M-25.70%
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Employees
49
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
Search
Clear search
Close search
Google apps
Main menu